An Immune Signature Robustly Predicts Clinical Deterioration for Hepatitis C Virus-Related Early-Stage Cirrhosis Patients

Hepatitis C virus (HCV)-related cirrhosis leads to a heavy global burden of disease. Clinical risk stratification in HCV-related compensated cirrhosis remains a major challenge. Here, we aim to develop a signature comprised of immune-related genes to identify patients at high risk of progression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Cheng, Dong, Chenglai, Zhang, Junjie, Wang, Rui, Wang, Zhe, Zhou, Jie, Wang, Wei, Ji, Bing, Ma, Boyu, Ge, Yanli, Wang, Zhirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326446/
https://www.ncbi.nlm.nih.gov/pubmed/34350203
http://dx.doi.org/10.3389/fmed.2021.716869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326446/
https://www.ncbi.nlm.nih.gov/pubmed/34350203
http://dx.doi.org/10.3389/fmed.2021.716869

Ejemplares similares